Knight Therapeutics (KHTRF) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.01
0.02
0.05
0.08

Details

Expected EPS
0.0037660328
Actual EPS
0.0138968
Surprise EPS
0.01
Surprise Percent
+269%

Description

Knight Therapeutics (KHTRF) has reported earnings of 0.0138968 per share for Q2 2025.

0 Comments

Share your thoughts